TickerFacts.

uniQure N.V. (QURE): Revenue

Annual figures by period end, from SEC filings.

$16.10M
Year ended 2025-12-31
$18.09M
Trailing 12 months to 2026-03-31
-46.7%
3-year compound annual growth
-15.6%
5-year compound annual growth
+4.3%
10-year compound annual growth
$524.00M2014-12-31: $6.14M2015-12-31: $10.58M2016-12-31: $25.10M2017-12-31: $13.11M2018-12-31: $11.28M2019-12-31: $7.28M2020-12-31: $37.51M2021-12-31: $524.00M2022-12-31: $106.48M2023-12-31: $15.84M2024-12-31: $27.12M2025-12-31: $16.10M$16.10M
2014-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$16.10M-40.6%2026-03-02, From 2025-01-01
2024-12-31$27.12M+71.2%2026-03-02, From 2024-01-01
2023-12-31$15.84M-85.1%2026-03-02, From 2023-01-01
2022-12-31$106.48M-79.7%2025-02-27, From 2022-01-01
2021-12-31$524.00Mn/m2024-02-28, From 2021-01-01
2020-12-31$37.51M+415.2%2023-02-27, From 2020-01-01
2019-12-31$7.28M-35.5%2022-02-25, From 2019-01-01
2018-12-31$11.28M-13.9%2021-03-01, From 2018-01-01
2017-12-31$13.11M-47.8%2020-03-02, From 2017-01-01
2016-12-31$25.10M+137.3%2019-02-28, From 2016-01-01
2015-12-31$10.58M+72.3%2018-03-14, From 2015-01-01
2014-12-31$6.14Mn/a2017-03-15, From 2014-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
uniQure N.V. (QURE)2025-12-31$16.10M-40.6%
Opus Genetics, Inc. (IRD)2025-12-31$14.20M+29.1%
Arbutus Biopharma Corp (ABUS)2025-12-31$14.08M+128.2%
Pyxis Oncology, Inc. (PYXS)2025-12-31$13.86M-14.2%
CV Sciences, Inc. (CVSI)2025-12-31$13.79M-12.2%
Sol-Gel Technologies Ltd. (SLGL)2025-12-31$19.39M+68.0%
Palatin Technologies Inc (PTN)2026-06-30$13.19Mn/a
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.11M+29.8%
Evommune, Inc. (EVMN)2025-12-31$13.00M+85.7%

Compare QURE, IRD, ABUS, PYXS side by side · Screen every company in Pharmaceutical Preparations ↗